Sprifermin (AS902330) in Cartilage Injury Repair (CIR)

Clinical trial NCT01066871 · TERMINATED

Trial details

NCT number: NCT01066871
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Isolated Cartilage Injury of the Knee

Start date: 2010-03-01
Primary completion: 2013-04-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.